Bristol Meyers Squibb: This Dividend Contender Is A Steal Right Now (NYSE:BMY)

PM Images/DigitalVision via Getty Images

Introduction

If you invested in Bristol Myers Squibb Company (NYSE:BMY) over the past few years, you’re probably not happy with your return. Pharmaceutical companies are considered controversial and can often lead to some big